Latest / Pharmacy Podcast Network / NASP 2024 Annual Meeting LIVE ReCap Show Part Three | NASP Specialty Pharmacy Podcast
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:24Speaker 2: Welcome back to the Pharmacy Podcast Networks coverage of the
- 0:27Speaker 2: NASP twenty twenty four. We're thrilled to be back interviewing
- 0:31Speaker 2: specialty pharmacy leaders with our special four part series covering
- 0:35Speaker 2: the annual meeting and expo held in Nashville from October
- 0:38Speaker 2: sixth through the ninth. As the official press and media
- 0:40Speaker 2: partner for NASP, we're here to bring you the latest
- 0:43Speaker 2: insights and highlights from this important gathering. This year, industry
- 0:47Speaker 2: thought leaders and healthcare veterans from across the nation united
- 0:50Speaker 2: to discuss the future of specialty pharmacy in the evolving
- 0:53Speaker 2: patient journey. Here's part three of the PPN special coverage
- 0:56Speaker 2: of the NASP twenty twenty four, with an interview from
- 0:59Speaker 2: our sponsor, Paragon Pharmacy three to sixty.
- 1:02Speaker 3: Alright, this is Ted Mils, CEO of Paragon Hell three
- 1:04Speaker 3: sixty and you're listening to any ASP podcast.
- 1:08Speaker 4: Some people say the birthplace of specially Pharmacy is Pittsburgh, Pennsylvania,
- 1:12Speaker 4: and then those people from Orlando will argue the Pittsburghers
- 1:16Speaker 4: and say that it's Orlando, but I think it's a
- 1:18Speaker 4: combination between Pittsburgh and Orlando. And I don't know, doctor
- 1:23Speaker 4: Chris Antipas from Pittsburgh, which one do you think it is?
- 1:27Speaker 5: Well, it's definitely Pittsburgh. And actually the Orlando became a
- 1:33Speaker 5: specially pharmacy spot because folks from Pittsburgh. Don Howard, if
- 1:39Speaker 5: that's the name some people might know, Donnie Howard, he
- 1:42Speaker 5: liked to golf, so he moved his Pittsburgh specialty pharmacy
- 1:46Speaker 5: cure script to Orlando so that he could be there,
- 1:49Speaker 5: and from there it blossomed obviously. But for sure Pittsburgh
- 1:52Speaker 5: is the birthplace with Statlanders and you know the innovation
- 1:56Speaker 5: that took place there, I don't know how many more
- 1:59Speaker 5: than a decade, two decades ago, probably very much.
- 2:02Speaker 4: So out of that was also birthed your career and
- 2:07Speaker 4: everything that you've done, starting with ASTES, growing out through
- 2:11Speaker 4: your understanding and knowledge, giving back to your school of pharmacy,
- 2:15Speaker 4: and just what you've been active in also the Pennsylvania
- 2:17Speaker 4: Pharmacists Association of your time there as president. But this
- 2:20Speaker 4: is something that we're talking about today here at NASP
- 2:23Speaker 4: twenty twenty four is what's special coming out of Pittsburgh,
- 2:27Speaker 4: and that is Paragon Pharmacy three sixty and your attention
- 2:32Speaker 4: to your patients because you understand it's a different environment.
- 2:37Speaker 6: We're not talking about.
- 2:39Speaker 4: You quick fills and getting people out the door. This
- 2:42Speaker 4: is a slow down process. This is paying attention to
- 2:44Speaker 4: the details. Talk to us about where Paragon started. I
- 2:50Speaker 4: think it was called Valor Pharmacy.
- 2:52Speaker 7: Yeah, it was Valida, Valida.
- 2:54Speaker 5: Yeah, so Paragon's roots really came out of a retail
- 2:58Speaker 5: pharmacy any independent specialty pharmacies of current and president past.
- 3:08Speaker 5: It came out of a need from our community. We
- 3:10Speaker 5: were high volume retail pharmacy still are today, and we
- 3:15Speaker 5: had patients just asking for help. Hey, I'm struggling. My
- 3:18Speaker 5: doctor wrote me this prescription for this cancer medication. Can
- 3:22Speaker 5: you help us? And we said sure, we can look
- 3:26Speaker 5: into it, and we began uncovering and learning that you know,
- 3:29Speaker 5: there is a different process out there. To your point,
- 3:31Speaker 5: it's not the same as a retail pharmacy experience. There's
- 3:35Speaker 5: a lot more diligence that we have to do for
- 3:36Speaker 5: an individual prescription. That was in twenty fourteen and it
- 3:41Speaker 5: led us to open a specialty pharmacy. We called it Volda,
- 3:45Speaker 5: and we grew, we grew it into a dual a
- 3:48Speaker 5: credited fifty state licensed pharmacy, and then interestingly came across
- 3:54Speaker 5: some folks my now CEO, Ted Mills, who had founded
- 3:59Speaker 5: a technology company really aimed at helping patients and support
- 4:05Speaker 5: them in their nutritional journey, in their health nutritional journey,
- 4:11Speaker 5: and his company had built some very interesting technology, both
- 4:16Speaker 5: hardware and software, and one of my business partners had
- 4:22Speaker 5: this interesting idea that said, you know this technology that
- 4:24Speaker 5: you've built, Ted, it would be really interesting if it
- 4:27Speaker 5: had an application in pharmacy. And twelve months later we
- 4:32Speaker 5: had merged our companies and that was when Paragon was born.
- 4:36Speaker 5: And so Paragon is the formation of a community inspired
- 4:46Speaker 5: specialty pharmacy with all of the core values of a
- 4:52Speaker 5: community pharmacy that a pharmacy that actually cares, truly does,
- 4:57Speaker 5: legitimately care about the people they serve, and a technology
- 5:03Speaker 5: digital healthcare organization that was also formed on the basis
- 5:08Speaker 5: of taking care of people and really truly caring. Ted
- 5:11Speaker 5: has some personal stories that motivated him to get into this,
- 5:14Speaker 5: because I can tell you healthcare is not an easy
- 5:17Speaker 5: industry to be in.
- 5:18Speaker 7: It's tough. You either have to be so.
- 5:26Speaker 5: I hate to call it, be so lucky that you
- 5:28Speaker 5: just kind of strike a chord and you're able to
- 5:30Speaker 5: sustain a business in this industry, or you have to
- 5:33Speaker 5: really be passionate about helping people because you get kicked
- 5:36Speaker 5: in the face a lot, and so Ted truly does.
- 5:42Speaker 5: His motivation was related to his passion for helping folks
- 5:45Speaker 5: where he had some family members that didn't get the
- 5:48Speaker 5: care that they deserve. And so Paragon's identity is that
- 5:53Speaker 5: it's a digital health technology focused specialty pharmacy. That level
- 6:00Speaker 5: just technology that we've created. We have engineers in house.
- 6:03Speaker 5: None of this is outsourced. This is all in house engineers,
- 6:07Speaker 5: and we're trying to advance our profession, advance our engagement
- 6:13Speaker 5: with our patients by leveraging technology in creative ways. Because
- 6:17Speaker 5: everyone knows healthcare is the last to adopt any type
- 6:21Speaker 5: of technology, we're still in the stone ages in a
- 6:24Speaker 5: lot of respects. So that's Paragon's identity and what we're
- 6:28Speaker 5: trying to accomplish. And over the last twenty four months,
- 6:31Speaker 5: we've had some tremendous success in various areas of the
- 6:35Speaker 5: partners that we're serving and working with not only our patients,
- 6:39Speaker 5: but the payer partners that we engage with in some
- 6:42Speaker 5: of our limited payer networks, and also the drug manufacturer
- 6:46Speaker 5: partners that have entrusted servicing their patients and the patients
- 6:51Speaker 5: on their products to get them their medications timely and
- 6:55Speaker 5: support them with all the clinical care that they deserve.
- 6:58Speaker 4: Especially pharmacies. And a complex jigsaw puzzle that you have
- 7:02Speaker 4: to hand pick your partners. You have to handpick the
- 7:06Speaker 4: condition that you're really going to become a subject matter
- 7:08Speaker 4: expert in your patients are trusting that the technology that
- 7:12Speaker 4: you employ must work, it can't slow down processes. Let's
- 7:16Speaker 4: talk about one of the partners that you've kind of
- 7:19Speaker 4: led towards and chosen, which is the payer. What payers
- 7:23Speaker 4: out there are looking and seeing the level of quality
- 7:28Speaker 4: that you're delivering that have said, Wow, this organization for
- 7:32Speaker 4: our membership is making sure that they're taken care of
- 7:36Speaker 4: and they recognize that and they've really built something special
- 7:39Speaker 4: with you.
- 7:39Speaker 7: Yeah.
- 7:40Speaker 5: Interestingly, on the payer side, and we do a lot
- 7:42Speaker 5: of work in the self ensured employer space, so we
- 7:46Speaker 5: work with PBMs that support self funded employers and in
- 7:53Speaker 5: that setting. It's interesting because the specialty pharmacy experience is
- 7:57Speaker 5: often tied to the plan. It's tied to the PBM,
- 8:01Speaker 5: it's tied to the health plan. And when you're a
- 8:04Speaker 5: self funded employer, and I, you know, those that know
- 8:07Speaker 5: me know that I have a ton of experience in
- 8:08Speaker 5: this space. I help advise employers on how to manage
- 8:13Speaker 5: their self funded benefit for pharmacy. But they it's really
- 8:19Speaker 5: critical for them. It's a critical part of an employer's
- 8:22Speaker 5: offering to their employees the healthcare benefit, and this is
- 8:26Speaker 5: something that they're very sensitive to the experience of the member.
- 8:32Speaker 5: And the specialty pharmacy is also very important because these
- 8:38Speaker 5: are the members on their plan that are dealing with
- 8:39Speaker 5: the most critical health circumstances and they for good reason,
- 8:47Speaker 5: they need to be advocates. And so they're what we
- 8:51Speaker 5: call noisy. They're loud, and when something doesn't go right
- 8:55Speaker 5: as they should, they raise their hand and say, hey,
- 8:58Speaker 5: this is a problem, this is not good. And I
- 9:00Speaker 5: think that the employers, the PBMs that serve these employer
- 9:04Speaker 5: sponsored plans, they're very sensitive to the experience and having
- 9:10Speaker 5: a white glove experience, which is a you know, it's
- 9:13Speaker 5: a cliche. We hear this buzzword all the time, but
- 9:19Speaker 5: when that experience does come to fruition, there's a lot
- 9:23Speaker 5: of positive feedback and it leads to it lends to growth,
- 9:26Speaker 5: it lends to new opportunities.
- 9:28Speaker 7: So simple, it's a simple approach. It's a culture of caring.
- 9:32Speaker 5: And as anyone listening to this knows that as organizations
- 9:35Speaker 5: get bigger, it's just the nature of just our society
- 9:41Speaker 5: that you grow, you hire people, and the new people
- 9:45Speaker 5: you hire over a period of time. When you get
- 9:47Speaker 5: to thirty forty fifty, one hundred and two hundred people
- 9:50Speaker 5: in an organization, they are further and further from the
- 9:55Speaker 5: impetus the start of that company. And so and we
- 9:58Speaker 5: all have to recognize that these people have they have lives,
- 10:02Speaker 5: Like they have a job. They've got to come in,
- 10:04Speaker 5: clock in take care of the patients, but they got
- 10:06Speaker 5: to go home their son or daughter has their softball
- 10:09Speaker 5: or their baseball game, or they've got their mom is
- 10:12Speaker 5: in the hospital because they've got their own life challenges.
- 10:15Speaker 5: It's like we talk about social determinants of health, which
- 10:18Speaker 5: are real, legitimate social determinants of work, and social determinants
- 10:24Speaker 5: of delivering healthcare is what degrades quality, and we are
- 10:31Speaker 5: aware of this at Paragon and our vision and our
- 10:35Speaker 5: strategy and how we're combating this is to touch every
- 10:40Speaker 5: person in our organization to make sure that they are
- 10:44Speaker 5: aware of and infused with on a regular basis, this
- 10:47Speaker 5: culture of taking care of patients, taking care of them
- 10:50Speaker 5: as if it's their own child that needs that medicine,
- 10:53Speaker 5: and not letting that patient be left behind or lost
- 10:57Speaker 5: to this complex process that you described, Chris.
- 11:01Speaker 4: When we return, listeners, don't go anywhere. We're gonna jump
- 11:05Speaker 4: into the digital health phase of what Paragon has built.
- 11:09Speaker 4: This is my favorite part. So you're not gonna want
- 11:12Speaker 4: to miss this. We'll be right back.
- 11:15Speaker 2: You don't want to miss this. Meet Paragon Pharmacy three sixty,
- 11:19Speaker 2: a leader in elevated pharmacy care designed to help patients
- 11:22Speaker 2: achieve their health goals. Experience the future of pharmacy with
- 11:26Speaker 2: Paragon Pharmacy three sixty. Discover how we are redefining healthcare
- 11:30Speaker 2: by empowering pharmacists to drive better outcomes, manage costs, and
- 11:34Speaker 2: elevate patient care. Discover more at Paragonpharmacy three sixty Dot org.
- 11:42Speaker 6: Hey we are here.
- 11:43Speaker 4: NASPA twenty twenty four in Nashville. I'm here with doctor
- 11:48Speaker 4: Chris Antipas, pharm d entrepreneur mogul of pharmacy.
- 11:54Speaker 6: Can I call you a mogul?
- 11:55Speaker 8: Sure?
- 11:55Speaker 7: I love that.
- 11:58Speaker 4: Nashville. This has been a spy gathering. I've never been
- 12:01Speaker 4: to downtown Nashville.
- 12:02Speaker 6: I've flown through Nashville.
- 12:05Speaker 4: I went down to the I guess to call it
- 12:07Speaker 4: the nash Bash last night party.
- 12:09Speaker 6: It was so much fun. Have you and your wife kids?
- 12:12Speaker 6: Have you come to Nashville and hung on?
- 12:14Speaker 9: No?
- 12:14Speaker 5: I haven't, and I've been here for there. You know,
- 12:17Speaker 5: there are meetings that happen here at times and you're
- 12:20Speaker 5: you're stuck inside exactly. I mean, this city has got
- 12:23Speaker 5: a lot going on literally every and those that do
- 12:26Speaker 5: frequent here. No, it's live music everywhere. Yeah, and everybody's amazing.
- 12:30Speaker 6: It's not only that they're nice.
- 12:31Speaker 7: Yeah.
- 12:32Speaker 4: And they say this is one of the safest cities
- 12:34Speaker 4: in the entire United States. And I felt I felt
- 12:36Speaker 4: super safe last night. That people were having fun. And
- 12:38Speaker 4: so I don't know what they're sprinkling in the water,
- 12:40Speaker 4: but it's working well.
- 12:41Speaker 6: Well, a goalpost. They sprinkled the goal post in.
- 12:44Speaker 5: God, how about that that is unbelievable. Is yeah, it's unreal.
- 12:48Speaker 5: It's beautiful. It's that we've you know, thank God had
- 12:51Speaker 5: good weather. It's just been it's been a great experience.
- 12:54Speaker 5: This is a great town. And uh, there's been a
- 12:58Speaker 5: lot of great discussion here at this conference an ASPS.
- 13:01Speaker 5: You know, they're growing for good reason. They're growing because
- 13:04Speaker 5: of the quality of the organization. And Sheila, she's just top.
- 13:08Speaker 4: No, this is a record setting an ASP event. I
- 13:11Speaker 4: think there's over sixteen hundred attendees, if not more. Sorry
- 13:14Speaker 4: if I underquoted that, Sheila.
- 13:17Speaker 6: But what I'm.
- 13:18Speaker 4: Excited about is that digital health that we've been talking
- 13:22Speaker 4: about for ten years is finally real and Paragon Pharmacy
- 13:28Speaker 4: three sixty it's embedded into the DNA of your organization.
- 13:33Speaker 4: Talk to us about Modesto because I love this story
- 13:36Speaker 4: and I'm not sure if people that are listening, I'll
- 13:38Speaker 4: realize what you've built. Ted Mills, your CEO had a company.
- 13:44Speaker 4: He was using the technology in the nutritional space. You
- 13:48Speaker 4: recognized it. You guys fused it together. Talk to us
- 13:51Speaker 4: about how Modesto sets you apart.
- 13:54Speaker 5: Yeah, so Modesto the early days you were really interested in
- 14:01Speaker 5: this notion of leveraging hardware to take care of patients.
- 14:04Speaker 5: And when we track, I often say medication adherence is
- 14:09Speaker 5: not an outcome, it's a means to an outcome. And
- 14:11Speaker 5: some in my c session yesterday heard me preach this,
- 14:14Speaker 5: and I preach it all the time. Medication adherence is
- 14:17Speaker 5: a reflection of when a prescription was filled. It's not
- 14:19Speaker 5: a reflection of whether a patient took their medication. And
- 14:22Speaker 5: so we were really hung up on this notion of
- 14:24Speaker 5: how do we help support patients when they are not
- 14:27Speaker 5: taking their meds And that was kind of the inspiration
- 14:30Speaker 5: of Modesto, and that involved the creation with our engineering team.
- 14:37Speaker 5: We have electrical engineers, mechanical engineers that pulled together physical
- 14:42Speaker 5: devices that help support patients by knowing as close as
- 14:49Speaker 5: we can practically get whether or not they took a
- 14:51Speaker 5: dose of their medication, and when they don't take that dose,
- 14:54Speaker 5: they're getting nudges to say, hey, Todd, don't forget it's
- 14:57Speaker 5: important to take your medication. We're using a variety of
- 15:01Speaker 5: hardware technologies to do that. That kind of blossomed into well,
- 15:06Speaker 5: what other hardware can we leverage to engage with our patients?
- 15:10Speaker 5: And so we thought it might be nice to know
- 15:12Speaker 5: whether our patients that you know, this is specialty and
- 15:16Speaker 5: non specialty, whether there you know, is there blood pressure okay?
- 15:19Speaker 5: And so tying in leveraging APIs to pull in other
- 15:23Speaker 5: devices to track patients KPIs their their biometrics, blood pressure,
- 15:28Speaker 5: oxygen saturation weight. You know Medicare pays for RPM, and
- 15:34Speaker 5: so we thought, you know, there's.
- 15:35Speaker 7: A strategy here.
- 15:36Speaker 5: This can be diversified into a number of use cases
- 15:39Speaker 5: to help support our patients and all along all of
- 15:42Speaker 5: this information. As we're getting volumes and volumes of data,
- 15:47Speaker 5: we have reflected over the last twelve months that we
- 15:50Speaker 5: need to build something that supports all of this information
- 15:53Speaker 5: coming to us because as a pharmacy, we've got a
- 15:55Speaker 5: lot of data on our patients, just their dispensing history,
- 15:58Speaker 5: their provider, their medical history. But now we're getting all
- 16:02Speaker 5: of these other data points from patients. And one of
- 16:06Speaker 5: the critical areas of our industry is conducting clinical assessments
- 16:10Speaker 5: with patients where we're asking them questions specific to their disease,
- 16:13Speaker 5: and that information is coming back into us. And so
- 16:16Speaker 5: having this volume of data, we have invested a ton
- 16:21Speaker 5: of effort and energy to build out our cloud based
- 16:26Speaker 5: platform called Modesto. That's our enterprise platform to help our
- 16:32Speaker 5: clinical team navigate the care management for our patients. And
- 16:38Speaker 5: it is what we have recognized is that when we
- 16:41Speaker 5: can build triggers and automation and prompts into the technology,
- 16:49Speaker 5: we're removing the human element that could cause us to
- 16:53Speaker 5: trip up and forget to do something or not follow
- 16:56Speaker 5: up or forget about a patient.
- 16:58Speaker 7: And Esto has proven to be able to do that effectively.
- 17:02Speaker 5: We are very proud of our partner in script Med
- 17:05Speaker 5: and Ovalon for the platform that we use to our
- 17:09Speaker 5: pharmacy management platform. It has a lot of capabilities and
- 17:13Speaker 5: we really deploy Modesto over top of our dispensing platform
- 17:19Speaker 5: to provide an unprecedented, in our opinion, unprecedented level of
- 17:23Speaker 5: patient engagement where you know, it's two way texting, it's
- 17:28Speaker 5: push notifications into our smartphone app, it's pushing assessments to
- 17:32Speaker 5: them so that they can respond to and not they're responding,
- 17:35Speaker 5: but also the system is interpreting their responses and it's
- 17:38Speaker 5: guiding our clinicians to ensure that no flag gets unaddressed,
- 17:43Speaker 5: and you know, leveraging the technology to pull other data
- 17:47Speaker 5: out of their home, depending on the circumstance, and we
- 17:49Speaker 5: don't use everything in every circumstances. It's kind of a
- 17:54Speaker 5: customize the tool to support the patient. This kind of orchestra,
- 18:00Speaker 5: if you will, of our pharmacy processes, our culture of
- 18:07Speaker 5: truly caring about our patients, and this technology that is
- 18:12Speaker 5: giving us the support to have visibility to our patients
- 18:17Speaker 5: and these prompts that I'm referring to, these nudges for
- 18:20Speaker 5: not only the patient but also our teams. It's delivered
- 18:24Speaker 5: outcomes that are materially relevant to our partners. Those are
- 18:28Speaker 5: both payers, but especially our drug manufacturer partners that are
- 18:31Speaker 5: looking at Paragon and saying, wow, you guys are top
- 18:34Speaker 5: in our network. We have access to several limited distribution products,
- 18:38Speaker 5: some smaller networks, and Paragon is at the top.
- 18:41Speaker 7: It's well, how is that, why is that? What are
- 18:43Speaker 7: you doing differently?
- 18:44Speaker 5: Well, it's that every single patient matters. And I'm looking
- 18:47Speaker 5: at that referral not just as a piece of paper
- 18:49Speaker 5: with a name on it and a drug name on it,
- 18:52Speaker 5: but actually as the person and I'm thinking, Man, if
- 18:55Speaker 5: we don't get them their meds, it's not the right
- 18:57Speaker 5: thing to do. Forget about the business drivers. Forget about
- 19:00Speaker 5: the business relationship. It's these people need us and if
- 19:03Speaker 5: we're going to embrace this responsibility, we need to be
- 19:06Speaker 5: accountable to it. And that culture combined with this technology
- 19:10Speaker 5: that is you know the benefit of Ted and his
- 19:14Speaker 5: team that came together with my team now our team.
- 19:19Speaker 5: They are outsiders. It's like we have this practicality of
- 19:23Speaker 5: you know, it's pretty practical to prioritize these things in industry,
- 19:28Speaker 5: we kind of can get blinders on. And so having
- 19:30Speaker 5: this outsider's perspective, this culture, this desire to really just
- 19:35Speaker 5: do the right thing and build a successful business as
- 19:38Speaker 5: a side effect of doing the right thing, it's led
- 19:41Speaker 5: us to some prosperity here.
- 19:43Speaker 7: That's just the beginning.
- 19:43Speaker 5: I mean, we're gaining momentum and it's really exciting.
- 19:49Speaker 7: Frankly.
- 19:49Speaker 4: So a scenario, you and Ted walk into a meeting
- 19:53Speaker 4: with a pharma manufacturer. You sit down at you at
- 19:56Speaker 4: the conference table. Are you sharing data from the Modesto
- 20:01Speaker 4: portfolio that shows multi components of how you're surrounding the
- 20:05Speaker 4: patient with measurement with data collection? Talk to us about
- 20:10Speaker 4: how you are using the outcome data of Modesta to
- 20:15Speaker 4: tell the manufacturer Listen, we're here for the patient. We're
- 20:19Speaker 4: not here to make you manufacture successful. We're here to
- 20:22Speaker 4: make the patient.
- 20:23Speaker 10: Well.
- 20:24Speaker 6: However, if you use us, you are going to see success.
- 20:27Speaker 6: Like talk to us about that part.
- 20:28Speaker 5: Yeah, it's about So it's it's hard to visualize because
- 20:31Speaker 5: again we're we've created this and it's not it's not
- 20:34Speaker 5: like it's on billboards letting people see, oh, this is
- 20:37Speaker 5: what it looks like.
- 20:38Speaker 8: So we we.
- 20:39Speaker 5: Definitely come in and our our number one objective is
- 20:43Speaker 5: just take a look at the platform, letting them see it,
- 20:46Speaker 5: letting them look at individual patients.
- 20:47Speaker 7: And their journey through the system.
- 20:49Speaker 5: And you know, I've been around the block for you know,
- 20:52Speaker 5: more than a decade here, and I've seen some great
- 20:54Speaker 5: companies and you know, seen a lot of great stuff.
- 20:57Speaker 5: But we submit with humans that we don't think others
- 21:02Speaker 5: are doing what we're doing. And when we talk to
- 21:04Speaker 5: folks who are like, well, I've never seen that, So
- 21:06Speaker 5: I don't want to assume that other organizations are, you
- 21:11Speaker 5: know that we're I don't preach that we're the only
- 21:13Speaker 5: ones that are doing this. We just say we haven't
- 21:15Speaker 5: seen anyone else doing this, And then when we show
- 21:18Speaker 5: them the platform, we show them the depth of the communication.
- 21:22Speaker 5: So it's really centered around a few areas. One is
- 21:26Speaker 5: communicating with our patients and communicating with the provider, communicating
- 21:31Speaker 5: with the manufacturer teams. So within our system, we've built
- 21:34Speaker 5: a communication platform that enables hip a compliant messaging back
- 21:42Speaker 5: and forth. So whether we're engaging with the drug manufacturers,
- 21:45Speaker 5: field reimbursement specialists and team they're permitted to have access
- 21:49Speaker 5: to PHI, or we're communicating directly with the patient in
- 21:53Speaker 5: a hip a secure message because they're using our app,
- 21:56Speaker 5: or it's internal to our teams or the provider practices.
- 22:00Speaker 5: We just got feedback from one of our pharma partners
- 22:02Speaker 5: that one of the provider practices that is engaging with
- 22:05Speaker 5: us using our hiposecure Chat.
- 22:07Speaker 7: Their feedback back to the sales team was, this is unbelievable.
- 22:10Speaker 5: Thank you for connecting us to Paragon because it makes
- 22:13Speaker 5: our life so much easier. It literally has taken a
- 22:15Speaker 5: burden off of their shoulders. And so communication is a
- 22:19Speaker 5: core principle of our success. And to take that a
- 22:24Speaker 5: half step further in our bi directional texting with patients,
- 22:28Speaker 5: where we are able to send ad hoc text messages,
- 22:32Speaker 5: we can send text messages to cohorts of patients. So
- 22:35Speaker 5: if we want to send a text to one hundred
- 22:37Speaker 5: or five hundred patients or you name it patients, we
- 22:39Speaker 5: select them and click send the message. Those messages can
- 22:43Speaker 5: be scheduled, they can be triggered on a cadence. They
- 22:48Speaker 5: can include links, they can include PDFs, so communicating education
- 22:54Speaker 5: information reminders. I mean, we've built this without any limitation
- 23:00Speaker 5: obviously navigate regulatory hurdles, but as I said, you know,
- 23:04Speaker 5: our industry is very averse to adopting technology in part because.
- 23:08Speaker 7: They're so afraid of, well can we do this?
- 23:10Speaker 5: We can't do that, And obviously we're compliant focused and
- 23:13Speaker 5: we go through a core compliance consideration. But there are
- 23:16Speaker 5: ways to do this, there are ways to do it effectively,
- 23:19Speaker 5: and Modesto has really honed in on an effective way.
- 23:23Speaker 7: It's producing results. So when we show that to a partner.
- 23:27Speaker 5: As you pointed out in this in this conversation, they're like, wow,
- 23:29Speaker 5: that's amazing, and they start thinking like, oh, we could
- 23:32Speaker 5: do this, we could do that, or they're remembering when
- 23:34Speaker 5: they were told no by the prior partner or their
- 23:36Speaker 5: current partner.
- 23:37Speaker 7: That says yeah, we can't really do that.
- 23:40Speaker 5: And all of this is integrated into our system, so
- 23:43Speaker 5: it's going hand in hand with our management of the
- 23:46Speaker 5: prescription so that it's not like it's a bolt on, separate,
- 23:51Speaker 5: you know, separate product that you have to work to
- 23:54Speaker 5: try to integrate. Because we built it, integrated it into
- 23:57Speaker 5: our system and our workflows. It's you know, it's it's
- 24:01Speaker 5: very effective and streamlined. And so beyond the communication is
- 24:06Speaker 5: this notion of tracking patients, navigating them through the process.
- 24:12Speaker 5: And not only for our team to be able to
- 24:15Speaker 5: track patients and have the system alert us when there
- 24:18Speaker 5: is when there's divergence from our path that we've designed
- 24:23Speaker 5: as the appropriate path, but also that information, making it
- 24:27Speaker 5: visible to our clients, making it visible to our partners
- 24:30Speaker 5: so that they can log in they don't have if
- 24:32Speaker 5: they don't have hippa approval to c PHI, then they
- 24:36Speaker 5: see de identified information, but they can track on their
- 24:39Speaker 5: side in real time what's happening with the patients for.
- 24:42Speaker 7: Their particular product.
- 24:44Speaker 5: And it's so it's not only beneficial to us operationally,
- 24:47Speaker 5: but it's also beneficial from a reporting and an access
- 24:50Speaker 5: to information for a partners, and they gain confidence because
- 24:53Speaker 5: they're you know, these are in some cases, especially when
- 24:57Speaker 5: we're dealing with you know, newer, younger organizations that have
- 25:02Speaker 5: limited teams. Right, these manufacturers that have maybe this is
- 25:05Speaker 5: their only product on the market, they need to be
- 25:08Speaker 5: nimble to be able to respond to the market conditions
- 25:11Speaker 5: that are materially affecting their product and their providers, and
- 25:15Speaker 5: so access to that information through modesto is critical for them.
- 25:19Speaker 5: And then the third domain that I would highlight is
- 25:23Speaker 5: the access of information to you know, unique information from
- 25:26Speaker 5: the specific patient, which is a combination of the clinical
- 25:31Speaker 5: assessments that we're pushing out to patients for them, you know,
- 25:34Speaker 5: to respond to, or for us to you know, we still,
- 25:38Speaker 5: like many and most specialty pharmacies, we do assessments with
- 25:41Speaker 5: patients over the phone. But I mean, just think of
- 25:44Speaker 5: your own self, Like most people listening to this would say, well,
- 25:46Speaker 5: as opposed to doing this with someone over the phone,
- 25:48Speaker 5: can't I just can't you just send it to me
- 25:50Speaker 5: and I'll do it. I'll do it on my cell phone.
- 25:51Speaker 5: I'll just type in the answers they you know, our
- 25:55Speaker 5: patients are very appreciative of the ability to respond to
- 25:59Speaker 5: that information. But we're getting clinical assessment data, and then
- 26:03Speaker 5: we're applicable. We're getting this other data that nobody else
- 26:05Speaker 5: is getting, which is in this biometric data if we're
- 26:08Speaker 5: monitoring them. We have an integration with Apple health Kit,
- 26:11Speaker 5: we have an API, so you know, we could do
- 26:14Speaker 5: very creative things if you know, you look at the
- 26:16Speaker 5: latest Apple watches that are able to do so much more.
- 26:19Speaker 5: And we know that if just a few maybe in
- 26:22Speaker 5: the next couple of years at most Apple they have
- 26:25Speaker 5: some you know, patents to check blood glucose from the
- 26:28Speaker 5: Apple Watch. So and this is all of this to
- 26:33Speaker 5: being said, is all this being said? Doesn't even include
- 26:35Speaker 5: the conversation about AI. And while we don't actively deploy
- 26:40Speaker 5: AI today, it's it's in our product, it's in our
- 26:44Speaker 5: roadmap here, and it's being developed into our platform to
- 26:48Speaker 5: leverage it in the most appropriate of ways because it
- 26:52Speaker 5: can be controversial. So but you know, there the sky
- 26:56Speaker 5: is the limit. When when we think about this first,
- 26:59Speaker 5: like this is part of our core competency.
- 27:02Speaker 7: It infuses everything we.
- 27:03Speaker 5: Do and it's not like we're a specially pharmacy that
- 27:06Speaker 5: likes technology. We are a specialty pharmacy who is made
- 27:09Speaker 5: from technology. And when we're sitting down with our prospects
- 27:14Speaker 5: or our partners.
- 27:15Speaker 7: They just sit back and say, Wow, this is impressive.
- 27:18Speaker 5: It's almost too much, frankly, because we can overwhelm them
- 27:22Speaker 5: with all of the capabilities, but we also make sure
- 27:27Speaker 5: that we show them these anecdotes that apply use cases
- 27:31Speaker 5: that are specific for their product. And it's been pretty
- 27:36Speaker 5: phenomenal to.
- 27:37Speaker 7: Be able to do that well.
- 27:38Speaker 4: I appreciate Paragon Pharmacy being part of the naesp's post show.
- 27:42Speaker 4: This is important to get this messaging out to not
- 27:45Speaker 4: only other pharmacists who want to get into specialty, but
- 27:48Speaker 4: our payers that are listening, in our manufacturers that are
- 27:51Speaker 4: listening to reach out to doctor Antipas and his team
- 27:55Speaker 4: and Ted Mills. Please go to Paragonpharmacy dot org. Once again,
- 28:00Speaker 4: that's Paragonpharmacy dot org. Chris can't wait to have you
- 28:04Speaker 4: back in the studio down in Pittsburgh, South Pittsburgh, Brownsville.
- 28:07Speaker 4: And it's been great working with you here in Tennessee.
- 28:10Speaker 7: It's always a pleasure you are.
- 28:12Speaker 5: This is my plug for Todd and the Pharmacy Podcast Network.
- 28:16Speaker 5: There is nobody in the business that comes close to
- 28:19Speaker 5: Todd Yuri, so appreciate you. Todd, You are the best
- 28:22Speaker 5: and it's been a pleasure spending some time with you.
- 28:24Speaker 4: Thank you, Harry Travis, you're here in Nashville with me
- 28:31Speaker 4: at the NASP's booth.
- 28:33Speaker 6: It's so good to see you.
- 28:34Speaker 10: It is very good to see YouTube Todd. Great to
- 28:38Speaker 10: see you. It's a great meeting. Lots of energy, lots
- 28:41Speaker 10: of people.
- 28:42Speaker 6: Yes, a record for them, it is.
- 28:44Speaker 4: I think I think this is the largest attendance that
- 28:46Speaker 4: they've had.
- 28:47Speaker 6: Absolutely, we're very proud of this.
- 28:49Speaker 10: Yeah. The zhibit hall is just jam all right.
- 28:53Speaker 4: So you always give us perspectives on the state of
- 28:58Speaker 4: the nation for special pharmacy. So what I'd like to
- 29:01Speaker 4: do is ask you something very specific. Okay, lots of
- 29:05Speaker 4: demystification of artificial intelligence and specialty I've seen application where
- 29:12Speaker 4: it's amazing where there's people getting texts for follow up.
- 29:16Speaker 4: It's capturing the information, putting it back into some kind
- 29:20Speaker 4: of electronic health record, and then it's queuing some keywords
- 29:24Speaker 4: to then use those keywords to really kind of drive
- 29:27Speaker 4: next stages.
- 29:28Speaker 6: What are you seeing that's.
- 29:29Speaker 4: Really applicable in AI right now?
- 29:32Speaker 6: In specialty pharmacy, what.
- 29:34Speaker 10: I'm seeing is just an explosion of new companies and
- 29:39Speaker 10: entrepreneurs and early startups in the AI in the pharmacy
- 29:44Speaker 10: space that are kind of harnessing AI technology to solve
- 29:52Speaker 10: single point problems at every step in the prescription filming process.
- 29:57Speaker 10: So there are literally multiple companies he's working on, and
- 30:01Speaker 10: then you can kind of fill in the blank. Is
- 30:03Speaker 10: it benefit verification, is it dr is it revenue cycle management?
- 30:11Speaker 10: Is it copay assistance? Is it prior authorization? So every
- 30:16Speaker 10: step in the process of filling a prescription, there's multiple
- 30:21Speaker 10: companies working on a solution. So if you're a specialty pharmacy,
- 30:28Speaker 10: you really need to have somebody in your organization kind
- 30:33Speaker 10: of dedicated to, all, right, where are we going to
- 30:36Speaker 10: pick them first project? Where are we going to deploy
- 30:42Speaker 10: or try any AI vendor in some space You kind
- 30:46Speaker 10: of have to jump into the pool to learn how
- 30:48Speaker 10: to swim. And because there's just so much money being
- 30:53Speaker 10: spent on AI in general, that it's going to be
- 30:56Speaker 10: kind of like a supply side driven industry. These technologies
- 31:01Speaker 10: are going to be there, and they're going to want users,
- 31:03Speaker 10: and they're going everywhere to find a user too.
- 31:07Speaker 4: Perry, you always dabble in some of the more interesting
- 31:10Speaker 4: things that are happening in our profession. For example, you
- 31:13Speaker 4: help the entire country of Georgia assess their own ability
- 31:19Speaker 4: to grow within pharmacy. And you've worked with etech Dorx
- 31:24Speaker 4: in the past. They're fascinating with the digestible pill that
- 31:29Speaker 4: tells you data.
- 31:30Speaker 10: What are you.
- 31:30Speaker 4: Working on right now? Can you give us any insights
- 31:32Speaker 4: into your projects right now?
- 31:34Speaker 10: So right now, I have a large group of independent
- 31:39Speaker 10: former PBM and healthcare executives in a network that we
- 31:42Speaker 10: call our Roundtable that's helping early stage companies kind of
- 31:48Speaker 10: refine their pitch, look for kind of interesting connections in
- 31:54Speaker 10: the industry, maybe find rain makers, and we are kind
- 31:59Speaker 10: of harnessing tech the resources of all of those executives,
- 32:03Speaker 10: over one hundred and twenty of them primarily on the
- 32:05Speaker 10: AI space. So if there are AI companies out there
- 32:09Speaker 10: that want to test their pitch and get connected with
- 32:13Speaker 10: a lot of objective former health plan and PBM executives,
- 32:18Speaker 10: look me up.
- 32:19Speaker 7: That's great.
- 32:20Speaker 6: What's the best way to get a hold of you
- 32:21Speaker 6: through LinkedIn or LinkedIn?
- 32:23Speaker 10: Find Harry Travis on LinkedIn. Excellent, that's the way.
- 32:26Speaker 9: All right.
- 32:27Speaker 4: Thank you so much for being part of the NSP's
- 32:29Speaker 4: post show twenty twenty four.
- 32:31Speaker 6: We will see you in Denver next year.
- 32:34Speaker 10: That's right, that's right, Thanks a lot, all right, thanks bye.
- 32:43Speaker 8: Hello.
- 32:43Speaker 11: This is Jeff Wanzera, the CEO keep Labs, and you
- 32:46Speaker 11: are listening to the NEESP Pharmacy podcast.
- 32:49Speaker 4: Technology and Specialty Pharmacies one of my most favorite subjects
- 32:54Speaker 4: and how it plays into better patient care by empowering
- 32:57Speaker 4: a pharmacist who really understand specific disease state we're tracking
- 33:02Speaker 4: for something ancillary.
- 33:04Speaker 6: I'm excited to talk with.
- 33:06Speaker 4: Jeff with keep Labs, who's here at the NASP twenty
- 33:09Speaker 4: twenty four.
- 33:11Speaker 6: Welcome Jeff, Well, thanks.
- 33:12Speaker 8: For having me. Todd, pleasure to pleasure to be with you.
- 33:14Speaker 6: Well, introduce yourself to our listeners.
- 33:16Speaker 4: People really look forward to the NASP's recap show and
- 33:22Speaker 4: we've had some really innovative discussions this entire time.
- 33:25Speaker 6: Talk to us about yourself and key Labs.
- 33:27Speaker 11: So my background is my armaist by trade. I've taken
- 33:30Speaker 11: a very unconventional path into the technology, data and software world,
- 33:34Speaker 11: so found and sold two ventures in the digital health
- 33:37Speaker 11: landscape and getting involved from an operational standpoint as an
- 33:40Speaker 11: executive with a group called bioscript Solutions in Canada during
- 33:44Speaker 11: my time there and during the previous venture, as we
- 33:46Speaker 11: started to see that there was a significant gap when
- 33:48Speaker 11: it came to the information that we had our disposal
- 33:52Speaker 11: to proactively engage patients based on the real world behaviors
- 33:55Speaker 11: that we start to see with their specialty medications.
- 33:58Speaker 8: So this is where come into the fold.
- 34:00Speaker 11: And I often say that I'm a sucker for punishment,
- 34:02Speaker 11: So I keep going back to the startup well over
- 34:04Speaker 11: and over and over again, despite again a ton of fun,
- 34:08Speaker 11: but also as anyone's been involved in the startup kind
- 34:10Speaker 11: of early stage path, it's a ton of growth opportunities
- 34:12Speaker 11: and a lot of learning is along the way.
- 34:15Speaker 4: So what does Kate do specifically for disease sake tracking
- 34:20Speaker 4: and management and helping the pharmacists really dig into the
- 34:23Speaker 4: patient's care.
- 34:24Speaker 8: Yeah.
- 34:25Speaker 11: So if you think about the current construct in the
- 34:26Speaker 11: industry as we view claims, data is that gold standard
- 34:29Speaker 11: on understanding someone's engagement.
- 34:31Speaker 8: With their medication.
- 34:32Speaker 11: But the reality is on day one and day thirty
- 34:34Speaker 11: are the episodic touchpoints that we have, but the real
- 34:36Speaker 11: plot line is on a day by day or dose
- 34:38Speaker 11: by dose basis. So we said, how can we do
- 34:40Speaker 11: this in a way that meets patients on their terms,
- 34:42Speaker 11: unveils what's happening in the home, but not creating a
- 34:45Speaker 11: burden for either of our pharmacy staff or for the
- 34:48Speaker 11: patient themselves. So those really three four principles driving this
- 34:51Speaker 11: type of discussion in the platform is one passively capturing information.
- 34:55Speaker 8: So me and flude I thought this is a software.
- 34:57Speaker 11: Problem where we would create an app, we'd notify people
- 35:00Speaker 11: and they'd volunteer on a day by day or dose
- 35:02Speaker 11: by dose basis and say, but the challenge is that
- 35:04Speaker 11: you have a very difficult time having durable engagement over
- 35:07Speaker 11: an extended period. So you'd see someone use this for
- 35:09Speaker 11: a week, maybe two weeks at best, but then you
- 35:11Speaker 11: have gas gaps in the data on a significant basis.
- 35:14Speaker 11: And we defaulted to so let's use claims. Claims is
- 35:17Speaker 11: a great resource, and it is from a retrospective standpoint,
- 35:20Speaker 11: but there's no leading indicator, there's no essentially proactive way
- 35:23Speaker 11: in which we can help an individual based on real time,
- 35:27Speaker 11: real world behavior from the field. So we said, well,
- 35:29Speaker 11: someone's discontinue to treatment on a day five, we're waiting
- 35:32Speaker 11: at best day thirty one or by the time that
- 35:35Speaker 11: cut of data comes your ways typically two to three
- 35:37Speaker 11: months later from the aqb as or data aggregators in
- 35:40Speaker 11: the world, and we said, okay, well, how do we
- 35:42Speaker 11: have that snapshot in time in the patient's home on
- 35:44Speaker 11: a dose by dose basis? And that's kind of what
- 35:46Speaker 11: we said, So, how do we emulate the same way
- 35:48Speaker 11: that your Apple watcher fitfit is passively capturing or activity
- 35:51Speaker 11: data and opening up a whole new field of insights
- 35:53Speaker 11: on how do we best support and nudge behavior in
- 35:55Speaker 11: the right direction.
- 35:56Speaker 8: And that's really what we're doing for specialty medications.
- 35:58Speaker 11: On moving that dynasm rather than the pharmacy counter being
- 36:02Speaker 11: the end of the journey, to really just be in
- 36:03Speaker 11: the start up when that patient is starting to benefit
- 36:06Speaker 11: from their medications.
- 36:08Speaker 4: If there is a device component to this, it's a
- 36:12Speaker 4: really interesting box that you've retrofitted with tech, which is
- 36:17Speaker 4: just fascinating. Talk to our listeners about that from a
- 36:20Speaker 4: visual perspective, because sometimes when they're driving in their car,
- 36:24Speaker 4: they're walking, they're listening to a podcast, there's a visual
- 36:27Speaker 4: to this. So give us an idea of what this
- 36:29Speaker 4: device and how it plays in to keep Labs solutions.
- 36:33Speaker 11: Yeah, so the device itself is again one of the
- 36:36Speaker 11: core components to our platform. What we've said is, how
- 36:38Speaker 11: do we design a consumer electronic type of device that
- 36:41Speaker 11: could be retooled to repurpose in the enterprise setting. So
- 36:44Speaker 11: we want a Time magazine Best Invention and a med
- 36:47Speaker 11: tech Breakthrough reward. And what this essentially proved out is
- 36:50Speaker 11: that patients want to utilize the device. That's the fundamental
- 36:52Speaker 11: belief that we have to essentially have fulfilled. Otherwise, you
- 36:55Speaker 11: can create the most elegant looking, most episcated device, but
- 36:59Speaker 11: if patients aren't using it consistently, the whole platforms offer
- 37:01Speaker 11: and on. So with the accolades that we had, the
- 37:03Speaker 11: direct consumer demand, this is something that we've proven out
- 37:06Speaker 11: in the field. And this is where again it looks
- 37:09Speaker 11: like something that would be Apple esque, and that's one
- 37:10Speaker 11: of the best compliments we can get from people that
- 37:13Speaker 11: are ordering the device or it's like, okay, well, this
- 37:14Speaker 11: feels like an Apple type of experience where you're not
- 37:16Speaker 11: boxing it when you're setting up the ease of use.
- 37:18Speaker 11: So it typically takes our users about ninety seconds to
- 37:22Speaker 11: set up the device.
- 37:23Speaker 8: It's seamless, it's easy, and.
- 37:24Speaker 11: The esthetics allow it to be placed in a more
- 37:26Speaker 11: prominent place in the home. So most of the time,
- 37:28Speaker 11: when you get something from the healthcare setting, you're putting
- 37:31Speaker 11: it in the cupboard and the drawer, someplace where it
- 37:34Speaker 11: doesn't fit in with the decor in your home. But
- 37:36Speaker 11: the reality is if you have a more prominent place
- 37:38Speaker 11: in the home, the kitchen, living room, bedside table, and
- 37:41Speaker 11: this fits in, this is where you have the best
- 37:42Speaker 11: opportunity to engage people and a point where it's contextually relevant. So,
- 37:47Speaker 11: like I mentioned before and you alluded to, when you're
- 37:48Speaker 11: driving in the car, you're listening to a podcast, you
- 37:51Speaker 11: get a notification that your medications do at nine am,
- 37:53Speaker 11: but you can't take action to it, so you snooze that,
- 37:55Speaker 11: and then you're starting to essentially compete with Facebook, your emails,
- 37:58Speaker 11: your messages, and you're in this dark hole with your phone.
- 38:01Speaker 11: So we said, well, how do we have a contextual
- 38:03Speaker 11: relevant alert where the medication is stored and we have
- 38:05Speaker 11: the best opportunity to drive that passive type of engagement
- 38:09Speaker 11: in which we know or don't know a medication has
- 38:12Speaker 11: been taken. So this is where our fundamental belief is,
- 38:14Speaker 11: we have to have a prominent place in the home
- 38:17Speaker 11: and a device that patients are excited to use, and
- 38:19Speaker 11: then ultimately, how do we leverage our data in a
- 38:21Speaker 11: way that helps drive outcomes and that patient behavior in
- 38:24Speaker 11: real time versus just looking at it to aggregate it.
- 38:27Speaker 4: It looks like from the visual on the website and
- 38:30Speaker 4: for people listening in if you want to check out
- 38:33Speaker 4: Keep Labs, go to discover keep dot com. That's discover
- 38:38Speaker 4: keep dot com. And so in the on the website,
- 38:42Speaker 4: I see it's a it's a box that has some
- 38:45Speaker 4: digital interface messaging. How big is the is the actual appliance?
- 38:51Speaker 11: Yeah, So I'm trying to think of a good way
- 38:53Speaker 11: to describe it for the listeners who don't have a
- 38:55Speaker 11: visual in front of them. But I'd say, if you're
- 38:58Speaker 11: to take an eight and a half eleven sheet of paper,
- 39:00Speaker 11: hold that in half.
- 39:01Speaker 8: That's the inter dimensions that we're working with.
- 39:03Speaker 11: And it's about two thirds the size of an iPhone
- 39:06Speaker 11: from a height standpoint, so it's enough to fit ten medications.
- 39:09Speaker 11: And this is where we typically have this conversation with
- 39:11Speaker 11: our partners is do we want to support that one
- 39:13Speaker 11: specific product. Our thesis is we want to support the
- 39:16Speaker 11: full medication profile because that's what patients are looking to solve.
- 39:19Speaker 11: For so ten medications or some function of sub contaneous
- 39:22Speaker 11: injections or.
- 39:23Speaker 8: Although solids blister packs.
- 39:25Speaker 11: The other thing that it should mention is we believe
- 39:27Speaker 11: that we have to fit in the confines of a
- 39:29Speaker 11: regular workflow and rituals that either a patient or a
- 39:32Speaker 11: pharmacy have. So whether they're a customer to receiving their
- 39:35Speaker 11: medication in a pill bi and a blister pack, let's
- 39:37Speaker 11: not change anything like that. Let's make this as easy
- 39:40Speaker 11: as same as for people to adopt. And then that's
- 39:42Speaker 11: where we drive behavior change because we're not changing again
- 39:45Speaker 11: something that.
- 39:46Speaker 8: People are accustomed to.
- 39:47Speaker 11: It's giving the data and the nudges, but fitting into
- 39:49Speaker 11: the gun fines what they're again doing.
- 39:51Speaker 8: On their day to day basis versus completely upheaving that.
- 39:56Speaker 6: And do you find that because of the.
- 40:00Speaker 4: Expense side, the intensity around staying on medication, that this
- 40:05Speaker 4: fits really well into specially medication.
- 40:08Speaker 11: Yeah, So the complexity of specialty care, this is where
- 40:11Speaker 11: I think the resource that we have at our disposal.
- 40:12Speaker 11: So we think technology has a significant role to play
- 40:15Speaker 11: on providing the pharmacist with the right information to take
- 40:18Speaker 11: the right intervention step with the right.
- 40:20Speaker 8: Patients at the right time. So if you think.
- 40:22Speaker 11: About before we were blind to this whole experience in
- 40:24Speaker 11: the home, Well, how do we shift that dynamic and
- 40:26Speaker 11: give the information to a pharmacist or a clinical care
- 40:30Speaker 11: team member to essentially.
- 40:31Speaker 8: Say, out of this roster of a thousand people, these.
- 40:33Speaker 11: Are the ten individuals that have exhibited some form or
- 40:36Speaker 11: fashion of a real world behavior that could benefit most
- 40:38Speaker 11: from some type of health reachion intervention. So this is
- 40:41Speaker 11: what we kind of fundamentally believe is how do we
- 40:43Speaker 11: give our pharmacy team, our clinical partners the ability to
- 40:47Speaker 11: intervene And that is amplified on the specialty side. So
- 40:50Speaker 11: when you have the complexionity, you have the downtream consequences,
- 40:53Speaker 11: which is tolerability, unique dosing frequency, or some waning the
- 40:56Speaker 11: leaf in a medication, how can we connect individuals to
- 40:59Speaker 11: the right care resources. And the reality isn't specialty. We
- 41:02Speaker 11: have a lot more time, a lot more capacity, and
- 41:04Speaker 11: a lot more resources to really proveote this model. And
- 41:07Speaker 11: we do think what we prove out in the specialty
- 41:09Speaker 11: space can go down market.
- 41:10Speaker 8: So if you think about the specialty like.
- 41:12Speaker 11: Category or traditional community pharmacy, where we have again different demographics,
- 41:16Speaker 11: different patient gohorts, the learnings that we'll have in specialty
- 41:19Speaker 11: can be more broadly applied across the entire pharmacy from
- 41:22Speaker 11: the spectrum.
- 41:23Speaker 4: This has been really interesting. We hope to have you
- 41:25Speaker 4: back on maybe this week in Pharmacy or dig in
- 41:28Speaker 4: with an especialty pharmacy that's been one of the users
- 41:32Speaker 4: their patients have been using the KEEP technology. We really
- 41:36Speaker 4: appreciate you being part of the nesp's podcasting. Specialty pharmacy
- 41:43Speaker 4: is complex. I see a lot of twit tweets, I
- 41:46Speaker 4: see some discussions on LinkedIn. There's people that might not
- 41:50Speaker 4: understand specialty in thinking, oh, is that a trick to
- 41:55Speaker 4: generate more money for a PBM, so they can kind
- 41:58Speaker 4: of take what's happening. And then when I started thinking,
- 42:02Speaker 4: I started reading a lot of data. I started looking
- 42:04Speaker 4: at specialty and pharmacists that were starting to focus on geriatrics.
- 42:09Speaker 6: They were focusing on.
- 42:12Speaker 4: Rare disease and in your case, doctor Sean Francis, you're
- 42:16Speaker 4: focusing on children and that's very special. Introduce yourself and
- 42:21Speaker 4: share your background with us here on the NSP podcast.
- 42:25Speaker 9: Yeah.
- 42:25Speaker 12: Absolutely so pleasure to have you know me here, So
- 42:28Speaker 12: thank you Toad for that. So I'm Sean Francis, structor
- 42:31Speaker 12: of special de Farms. Yeah, Children's National Hospital, and one
- 42:34Speaker 12: of my background has been in corporate.
- 42:36Speaker 9: Retail at CBS Health.
- 42:38Speaker 12: You know, a lot of specialty pharmacy work at hospitals
- 42:40Speaker 12: and health systems, and then recently I have been you know,
- 42:42Speaker 12: in the last two years with Children's National Hospital and you.
- 42:45Speaker 9: Know, we really launched their selling.
- 42:47Speaker 12: Gene therapy program and you know, I gave opening remarks
- 42:51Speaker 12: at the session today this morning. So we're doing amazing
- 42:55Speaker 12: things here as a great form to do it at
- 42:56Speaker 12: the NAESP.
- 42:58Speaker 6: That's good to hear.
- 42:59Speaker 4: And when I opened up in the demystifying of specialty,
- 43:05Speaker 4: how does serving and caring for children, how does that
- 43:10Speaker 4: add another layer of complexity to the world of specialty pharmacy.
- 43:15Speaker 13: Yeah.
- 43:15Speaker 9: Absolutely.
- 43:15Speaker 12: I think the critical component here is that, you know,
- 43:19Speaker 12: it's not only that we're taking care of our children,
- 43:21Speaker 12: but it's also the family, and it's being able to
- 43:24Speaker 12: connect with the family because these specially medications, they're often complex.
- 43:29Speaker 9: In so many different ways, and you need a.
- 43:31Speaker 12: Good subject matter expert to help that family navigate through
- 43:35Speaker 12: the entire process.
- 43:37Speaker 9: You know.
- 43:38Speaker 12: And I think overall, you know, in the landscape prescribers
- 43:41Speaker 12: have about seventy five percent more assets per indication that
- 43:44Speaker 12: they can prescribe than they did ten years ago. And
- 43:47Speaker 12: I think there's a significant unmet need for us to
- 43:50Speaker 12: be able to educate and help support patients and families,
- 43:53Speaker 12: especially within pediatric population, into understanding this as well.
- 43:57Speaker 6: That's wonderful to hear.
- 43:59Speaker 4: What is it about the NASP that you enjoy coming
- 44:02Speaker 4: to this conference every year?
- 44:03Speaker 12: Yeah, the biggest thing that I enjoy the most is
- 44:07Speaker 12: it is so diverse and full of different stakeholders and
- 44:12Speaker 12: entities and companies and hospitals and health systems that all
- 44:16Speaker 12: have a unique background and a pathway into solving some
- 44:21Speaker 12: of these challenges that we face.
- 44:23Speaker 9: And everyone here is united on the front.
- 44:26Speaker 12: For the common goal for our patients and our families,
- 44:29Speaker 12: and I think it's really important to remember that and
- 44:32Speaker 12: it brings really the purpose of what we do every
- 44:34Speaker 12: single day.
- 44:35Speaker 4: Doctor Sean Francis, thanks so much for being part of
- 44:37Speaker 4: the NASP podcast.
- 44:39Speaker 9: Yeah, pleasure is mine. Thank you so much.
- 44:45Speaker 4: Richard Brooke is back NASP podcast.
- 44:48Speaker 6: You're starting to make this like a tradition, but you oh, you.
- 44:52Speaker 13: Know what, First of all, we're thankful that the podcast
- 44:55Speaker 13: is here and we're honored to be able to be
- 44:57Speaker 13: part of it.
- 44:59Speaker 4: I appreciate that, you know, the twenty twenty four annual
- 45:03Speaker 4: events very special for a multitude of reasons. The attendance
- 45:06Speaker 4: here is just nuts. It's i think one of the
- 45:09Speaker 4: biggest ever. But something that's very special that's happening you
- 45:12Speaker 4: brought to our attention is the expansion of our posters
- 45:15Speaker 4: and the information that's being driven there. Tell us the
- 45:17Speaker 4: story about how that's expanded.
- 45:20Speaker 7: Wow, that's a great question.
- 45:21Speaker 13: When NAS was forming, oh so many years ago, we
- 45:26Speaker 13: realized that there was a very challenging opportunity for specially
- 45:31Speaker 13: pharmacies to showcase what they did. And if you had
- 45:34Speaker 13: research focused on a disease date, many people would take
- 45:37Speaker 13: it to the clinical meeting, but there really wasn't a
- 45:40Speaker 13: venue to showcase what especially pharmacy did.
- 45:43Speaker 8: And when we.
- 45:44Speaker 13: Took over as the Abstraction Posters program, we had three
- 45:48Speaker 13: posters that first year we were actually focusing on that.
- 45:52Speaker 7: Now we're up to over one hundred, and I.
- 45:55Speaker 13: Would just welcome everybody who's at the meeting to go
- 45:57Speaker 13: back and take a look at the different posters out
- 45:59Speaker 13: there and see all the research that's being done to
- 46:02Speaker 13: get drugs into patients, and I don't mean just into patients,
- 46:07Speaker 13: but into their possession. There's posters here on assistance programs
- 46:12Speaker 13: and what they're using with non used medications to get
- 46:15Speaker 13: them to other patients as well.
- 46:17Speaker 6: And we have our own posters in addition to that.
- 46:21Speaker 6: What's your approachter on right now?
- 46:23Speaker 13: So the poster we're talking about this meeting is on
- 46:27Speaker 13: CGRP use in the migraine population. So you know headaches
- 46:31Speaker 13: are If anyone's ever suffered from a headache or migraine,
- 46:34Speaker 13: they know how impactful they.
- 46:36Speaker 7: Are on your ability to get things done.
- 46:38Speaker 13: And we've had this benefit of this new class of drug,
- 46:41Speaker 13: the CGRPs hitting the market a few years ago. Most
- 46:45Speaker 13: of them are handled through specialty pharmacies and they really
- 46:50Speaker 13: as our data showed is the allowance of specially pharmacies
- 46:55Speaker 13: and health plans to employees and patients to get these
- 46:58Speaker 13: medications has increased and we're seeing a reduction in lost
- 47:03Speaker 13: work time and payments made for people for absence benefits
- 47:07Speaker 13: once they're on these CGRPs. Now, this was an exploratory
- 47:11Speaker 13: study we did and we're I have some studies planned
- 47:13Speaker 13: to follow up on that. But you know, we think
- 47:17Speaker 13: that as we get more effective medicines in headache, migraine,
- 47:21Speaker 13: and all the other diseases that the specialty pharmacy community
- 47:25Speaker 13: folks to affect, we're seeing a lot of positives in
- 47:28Speaker 13: the world, especially pharmacy. Meds by definition tend to be expensive,
- 47:33Speaker 13: so there is an increase in the overall cost of medications.
- 47:37Speaker 10: But if you can have.
- 47:39Speaker 13: A life and exist and go to work and be
- 47:42Speaker 13: part of the community, that's a positive and we're very
- 47:45Speaker 13: excited to be able to showcase that we're seeing that
- 47:48Speaker 13: kind of result from these meds.
- 47:50Speaker 6: So specialty.
- 47:52Speaker 4: Since I've been in pharmacy now it's been twenty years,
- 47:55Speaker 4: I've seen major changes and even the certific the CSP
- 48:01Speaker 4: rising to give our pharmacists a very specific understanding of
- 48:05Speaker 4: specialty pharmacy. What's the next thing that you might see
- 48:09Speaker 4: on the prize And maybe it's not a fully baked
- 48:11Speaker 4: cake yet, but what are you seeing where specialty is going?
- 48:15Speaker 13: Well, I think that specially pharmas you recognizes how unique
- 48:19Speaker 13: each patient is. You know, we see a lot of portals,
- 48:23Speaker 13: access reminders, patient management solutions that are bringing brought to
- 48:28Speaker 13: market because you know, everybody might complain about the same problem,
- 48:34Speaker 13: but everybody's body metabolizes products differently.
- 48:39Speaker 7: They have a.
- 48:39Speaker 13: Unique set of comorbid coexisting conditions, and it's really important
- 48:45Speaker 13: to target the right patient with the right medication and
- 48:49Speaker 13: make sure they address their concerns about side effects and
- 48:52Speaker 13: what other pieces. And I haven't seen any community better
- 48:56Speaker 13: than SP that does that.
- 48:58Speaker 9: I agree.
- 48:59Speaker 4: I agree, Richard Brooke, Thank you so much for being
- 49:02Speaker 4: part of our NASP podcast again and always bringing us
- 49:06Speaker 4: insights and sharing and we appreciate your support of the
- 49:09Speaker 4: NAESP as well.
- 49:11Speaker 6: And thanks for having.
- 49:11Speaker 13: Me on this music city platform today.
- 49:14Speaker 3: Thank you.
- 49:20Speaker 4: One of the Pharmacy fifties most Influential people for twenty
- 49:25Speaker 4: twenty two announced in twenty twenty three, or is it
- 49:28Speaker 4: twenty three announced in twenty four I can't keep draft
- 49:31Speaker 4: of it was Eric Hupkins with Loumis Sarra Health.
- 49:35Speaker 6: I'm so excited that you're here.
- 49:36Speaker 7: Oh, appreciate it, Tyd.
- 49:38Speaker 8: You're too kind.
- 49:39Speaker 4: So you recently received a promotion from your hard work.
- 49:43Speaker 6: That's no surprise to me.
- 49:45Speaker 4: With how you really take a lot of pride in
- 49:49Speaker 4: the attention that you guys are giving to the end
- 49:52Speaker 4: all be all most important person, which is our patient
- 49:56Speaker 4: and which you guys are creating through Loumis Sarah, give
- 49:58Speaker 4: us an update on you, and then also what you
- 50:00Speaker 4: guys are doing at Loumis are now.
- 50:02Speaker 3: Yeah, it's been an exciting transition. Our organization has just
- 50:05Speaker 3: been growing immensely a lot of new partnerships and so
- 50:10Speaker 3: really my role as a VP of Business Development is
- 50:13Speaker 3: to expand those partnerships, find like minded organizations that are
- 50:20Speaker 3: interested and value that transparency in the supply chain.
- 50:24Speaker 7: And that's what we're doing well.
- 50:26Speaker 4: I like it, Eric, you and I have had conversations
- 50:30Speaker 4: off the mic. We kind of dig into the transparency
- 50:33Speaker 4: that's needed out there with the surging changes that we
- 50:38Speaker 4: see happening in our traditional PBM models, which is wonderful
- 50:41Speaker 4: because I think we're going to get away from the
- 50:44Speaker 4: dispensing fee and we're going to start concentrating on pharmacists
- 50:47Speaker 4: being paid for their clinical services and managing disease states
- 50:51Speaker 4: and conditions.
- 50:52Speaker 6: That's exciting.
- 50:53Speaker 4: But in specialty, Loomis Sarah has positioned yourselves as a
- 50:58Speaker 4: trusted beacon of that kind of transparency, and you gain
- 51:01Speaker 4: the attention of a major, major player, and I want
- 51:05Speaker 4: to announce this on the NASP's podcast. But tell us
- 51:09Speaker 4: about that special announcement of what you're working on.
- 51:11Speaker 3: Yeah, yeah, I mean exciting is an understatement. I mean,
- 51:15Speaker 3: we are gaining a lot of attention. One because the
- 51:19Speaker 3: market's ripe for it. You see what's going on with
- 51:22Speaker 3: the FTC and all the noise going on with the
- 51:27Speaker 3: lack of transparency in the supply chain, and so we
- 51:30Speaker 3: are excited now to really exemplify our commitment to transparency
- 51:36Speaker 3: by partnering with Costco and early launching a Costco specialty
- 51:40Speaker 3: pharmacy offering to the market that offers that passed through
- 51:45Speaker 3: transparent pricing along with Lumiserra's commitment for value that we
- 51:50Speaker 3: provide high touch service clinical programs now with a valued
- 51:55Speaker 3: partner like Costco, national name and brand that has a
- 52:00Speaker 3: like minded interest in providing a wonderful customer experience and
- 52:05Speaker 3: you know, providing value back to their customers and members.
- 52:08Speaker 3: So we're very excited about that, gaining a lot of attention.
- 52:11Speaker 3: A lot of plans want to participate and in that
- 52:16Speaker 3: type of model because it's it shows where their dollars
- 52:20Speaker 3: are being spent and how pharmacists can really provide be
- 52:25Speaker 3: an asset in that healthcare patient team to improve the
- 52:30Speaker 3: outcomes and health, which is you know, that's why I
- 52:32Speaker 3: went to pharmacy school, so I know a lot of
- 52:35Speaker 3: my fellow pharmacists. They will get up every day and
- 52:38Speaker 3: you know, see patients and it really is meaningful to
- 52:43Speaker 3: what we're doing.
- 52:45Speaker 4: You and I take it for granted because we're in
- 52:47Speaker 4: deep in the whole pharmacy landscape and business and tracking
- 52:54Speaker 4: and data and that's great, but the public doesn't understand
- 52:58Speaker 4: specialty number one and number two. There are people that
- 53:03Speaker 4: are wonderful fighters out there. For example, Mark Cuban, who
- 53:06Speaker 4: helped to start and fund Doctor Alex. He's the CEO
- 53:11Speaker 4: of Mark Cuban Costs Plus Drugs, and they've brought a
- 53:14Speaker 4: tremendous amount of public attention around transparency in the need
- 53:20Speaker 4: for that. However, Mark has made comments on Twitter and
- 53:25Speaker 4: on even news programs that specialty pharmacy is just a
- 53:30Speaker 4: mask for people.
- 53:32Speaker 6: Just wanting to take up more money.
- 53:34Speaker 4: And when I hear him say those things, as much
- 53:36Speaker 4: as I want his he's a cheerleader, he's amazing. We
- 53:40Speaker 4: need to set him down and let him know listen,
- 53:43Speaker 4: specially is drastically different than geriatric pharmacy or pediatric pharmacy
- 53:49Speaker 4: or general community pharmacy.
- 53:51Speaker 6: So what's the blend between.
- 53:53Speaker 4: We're talking about transparency, we want it, but we also
- 53:56Speaker 4: want to tell the public. But the differences in your
- 54:00Speaker 4: specialty pharmacists and how we're tracking that disease date and
- 54:03Speaker 4: making sure that technology is involved and making sure everything
- 54:07Speaker 4: gets paid for. What do you think about you know
- 54:10Speaker 4: that that knife's edge.
- 54:12Speaker 3: Yeah, well, I mean, first, first off, we are big
- 54:15Speaker 3: fans of what what Mark Cuban's doing and and really
- 54:19Speaker 3: shining a light to to something that needed attention as
- 54:23Speaker 3: far as being more transparent and showing you know the
- 54:28Speaker 3: true cost of goods and how there's some perverse incentives
- 54:32Speaker 3: in our.
- 54:33Speaker 10: Current current marketplace.
- 54:34Speaker 3: So we've been we've been lumis Are has been doing
- 54:37Speaker 3: you know, a form of cost plus and passed through
- 54:40Speaker 3: since our day we opened ten years ago. But it
- 54:43Speaker 3: has been always in that specialty pharmacy area and and
- 54:47Speaker 3: to your point, we really came into being to one
- 54:51Speaker 3: add transparency, but two equally important was that patient care.
- 54:55Speaker 3: These are patients that are on chronic, debilitating diseases requiring injections,
- 55:01Speaker 3: high cost treatments that are very complex, and so we've
- 55:06Speaker 3: focused our model in around this patient management fee. All
- 55:10Speaker 3: of our service is captured within that patient management fee,
- 55:14Speaker 3: and it really is helping that patient through the journey
- 55:17Speaker 3: and complexity of specialty treatments to make it a little
- 55:21Speaker 3: bit easier and prove the access for them, get them
- 55:24Speaker 3: on treatment sooner, make sure they're optimizing the treatment goals
- 55:29Speaker 3: and outcomes. Once again, that's all part of what we
- 55:32Speaker 3: do and what we've built for over ten years now.
- 55:37Speaker 4: Eric Hutkins, we really appreciate your insights here at NASP
- 55:41Speaker 4: twenty twenty four and look forward to working with Luis
- 55:44Speaker 4: Serra's team in the future in twenty twenty five.
- 55:47Speaker 6: Appreciate Ted, Thanks you pleasure hours